Price
Financials
Standalone, Rs crore| Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 52 | 97 | 101 | 106 | 94 | 120 | 87 |
| Expenses | 75 | 45 | 91 | 95 | 98 | 87 | 112 | 78 |
| Operating Profit | 5 | 7 | 6 | 6 | 8 | 8 | 8 | 9 |
| OPM % | 6% | 13% | 7% | 6% | 8% | 8% | 7% | 10% |
| Other Income | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | 1 | 2 | 1 | 2 | 2 | 2 | 3 | 3 |
| Depreciation | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 3 | 4 | 4 | 4 | 5 | 4 | 6 |
| Tax % | 62% | -1% | 20% | 32% | 23% | 30% | 26% | 32% |
| Net Profit | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| EPS in Rs | 0.78 | 2.61 | 1.96 | 1.56 | 2.01 | 1.86 | 1.88 | 2.19 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 126 | 107 | 94 | 130 | 191 | 196 | 203 |
| Expenses | 118 | 98 | 86 | 118 | 178 | 180 | 186 |
| Operating Profit | 8 | 9 | 8 | 12 | 13 | 16 | 17 |
| OPM % | 7% | 8% | 8% | 9% | 7% | 8% | 8% |
| Other Income | 0 | 1 | 0 | 1 | 2 | 1 | 2 |
| Interest | 2 | 2 | 2 | 3 | 3 | 5 | 5 |
| Depreciation | 2 | 3 | 2 | 4 | 3 | 3 | 3 |
| Profit before tax | 5 | 5 | 4 | 6 | 8 | 9 | 10 |
| Tax % | 30% | 25% | 25% | 27% | 26% | 26% | 29% |
| Net Profit | 3 | 4 | 3 | 4 | 6 | 7 | 7 |
| EPS in Rs | 2.69 | 3.08 | 2.34 | 3.39 | 3.52 | 3.86 | 4.08 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 14% | 16% | 3% | ||
| Compounded Profit Growth | % | 14% | 19% | 4% | ||
| Stock Price CAGR | % | % | 15% | 14% | ||
| Return on Equity | % | 9% | 9% | 8% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 17 | 17 | 17 |
| Reserves | 18 | 21 | 24 | 29 | 55 | 61 | 68 |
| Borrowings | 16 | 18 | 22 | 27 | 34 | 44 | 57 |
| Other Liabilities | 31 | 35 | 37 | 34 | 67 | 55 | 63 |
| Total Liabilities | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
| Fixed Assets | 12 | 13 | 11 | 16 | 22 | 22 | 16 |
| CWIP | -0 | -0 | 1 | -0 | -0 | -0 | -0 |
| Investments | -0 | -0 | -0 | -0 | 12 | 13 | 13 |
| Other Assets | 64 | 73 | 82 | 86 | 138 | 142 | 177 |
| Total Assets | 76 | 86 | 95 | 102 | 172 | 178 | 205 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3 | 4 | -0 | 2 | -8 | -2 | -8 |
| Cash from Investing Activity | -1 | -2 | -2 | -4 | -16 | -4 | 2 |
| Cash from Financing Activity | -3 | -1 | 1 | 1 | 24 | -5 | -9 |
| Net Cash Flow | -1 | 1 | -1 | -2 | 0 | -11 | -15 |
| Free Cash Flow | 2 | 1 | -2 | -3 | -13 | -5 | -4 |
| CFO/OP | 46% | 58% | 11% | 34% | -49% | 3% | -31% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 80 | 89 | 143 | 92 | 148 | 129 | 134 |
| Inventory Days | 93 | 159 | 137 | 104 | 99 | 126 | 170 |
| Days Payable | 72 | 108 | 137 | 79 | 131 | 113 | 127 |
| Cash Conversion Cycle | 100 | 140 | 143 | 116 | 117 | 141 | 177 |
| Working Capital Days | 50 | 74 | 93 | 86 | 86 | 89 | 105 |
| ROCE % | 14% | 11% | 14% | 13% | 12% | 12% |
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 70.01% | 70.01% | 70.01% | 70.01% | 70.01% | 70.01% |
| Public | 30.00% | 29.99% | 29.99% | 29.99% | 29.99% | 29.99% |
| No. of Shareholders | 2,064 | 1,858 | 1,602 | 1,465 | 1,219 | 1,060 |
Fundamentals
Market Cap₹ 108 Cr.
Current Price₹ 63.0
Stock P/E15.6
Book Value₹ 49.8
ROCE11.6 %
ROE8.45 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)3%
Compounded Profit Growth (TTM)4%
Standalone figures.
Valuation
Market capRs 75 Cr
Enterprise valueRs 102 Cr
P/E (TTM)18.55x
Price to book1.86x
Price to sales0.58x
EV / EBITDA8.12x
EV / EBIT11.52x
EV / sales0.79x
Price to cash flow33.25x
Earnings yield5.39%
Profitability
Operating margin (excl. other income)9.06%
Operating margin (incl. other income)9.68%
EBITDA margin9.68%
Pre-tax margin4.30%
Net profit margin3.13%
ROE10.63%
ROCE14.17%
ROA4.15%
ROE, 3-year average10.18%
ROCE, 3-year average12.96%
ROA, 3-year average3.93%
ROIC (approx.)9.58%
Tax rate27.37%
Other income / net worth1.97%
Growth
Sales growth (latest year)38.11%
Profit growth (latest year)44.84%
Sales CAGR, 3 years1.05%
Profit CAGR, 3 years8.01%
Per share
EPS (TTM)Rs 3.39
EPS (latest year)Rs 3.39
EPS, 3-year averageRs 2.94
Book value per shareRs 33.79
Sales per shareRs 108.24
Cash flow per shareRs 1.89
Free cash flow per shareRs -3.33
Efficiency
Asset turnover1.28x
Fixed asset turnover8.34x
Inventory turnover3.72x
Inventory days98 days
Debtor days91 days
Debtors turnover3.99x
Creditor days127 days
Cash conversion cycle177 days
Working capital days105 days
Leverage
Total debtRs 27 Cr
Cash and bankRs 0 Cr
Net debtRs 27 Cr
Debt to equity0.67x
Net debt / EBITDA2.12x
Interest coverage2.71x
Owners' fund to total sources39.92%
Debt to assets26.57%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -4 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs -4 Cr
FCFE (approx.: FCF + change in debt)Rs 1 Cr
Cash from ops / profit, 5 years-0.59x
Sales to cash flow57.22x
Statement figures
Net sales (TTM)Rs 130 Cr
Net sales (latest year)Rs 130 Cr
Operating profit excl. other income (latest year)Rs 12 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs 13 Cr
PBDT (TTM)Rs 9 Cr
Profit before tax (TTM)Rs 6 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 4 Cr
Net profit (latest year)Rs 4 Cr
Depreciation (TTM)Rs 4 Cr
Interest (TTM)Rs 3 Cr
Cost of goods sold (latest year)Rs 97 Cr
Total expenditure (latest year)Rs 118 Cr
Total income (latest year)Rs 131 Cr
Share capitalRs 12 Cr
ReservesRs 29 Cr
Shareholders' fundsRs 41 Cr
Total assetsRs 102 Cr
Net blockRs 16 Cr
ReceivablesRs 33 Cr
InventoryRs 26 Cr
Other liabilitiesRs 34 Cr
Shares outstanding (crore)1.20
Ownership
Promoter holding70.01% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 18.6 is at the 63th percentile of its own 3.2-year range
(median 16.9, low 12.7, high 26.0).
P/B 1.86 is at the 74th percentile (median 1.74).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | CLSL | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -10.2% | -2.8% | -7.4 pts |
| 1 month | -21.4% | -6.8% | -14.6 pts |
| 3 months | +49.2% | -7.6% | +56.8 pts |
| 6 months | +31.0% | +0.4% | +30.6 pts |
| 1 year | +20.7% | -9.9% | +30.6 pts |
| 2 years | +57.2% | -13.6% | +70.8 pts |
| 3 years | +50.8% | +14.2% | +36.7 pts |
Red flags
F-score 6 of 8| look | On NSE surveillance On NSE surveillance: ESM |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹87 Cr -13.9% vs Mar 2024.
Net profit ₹4 Cr +33.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| UPL Ltd | 45,402 | 23.0 | 10.1 % |
| P I Industries Ltd | 34,725 | 32.2 | 15.0 % |
| Sumitomo Chemical India Ltd | 21,521 | 37.7 | 23.5 % |
| Bayer CropScience Ltd | 16,191 | 22.1 | 29.1 % |
| Sharda Cropchem Ltd | 6,509 | 10.4 | 30.2 % |
| Dhanuka Agritech Ltd | 4,148 | 15.5 | 23.8 % |
| Rallis India Ltd | 3,882 | 17.0 | 14.1 % |
| Bhagiradha Chemicals & Industries Ltd | 3,128 | 114 | 4.53 % |
| NACL Industries Ltd | 3,101 | 120 | 8.13 % |
| GSP Crop Science Ltd | 2,198 | 21.0 | 18.9 % |
| Insecticides India Ltd | 1,706 | 13.6 | 15.8 % |
| Bharat Rasayan Ltd | 1,673 | 12.0 | 16.1 % |
| Astec Lifesciences Ltd | 1,552 | -5.44 % | |
| India Pesticides Ltd | 1,533 | 14.2 | 16.6 % |
| Meghmani Organics Ltd | 1,458 | 22.7 | 6.71 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
ESM: stage 1Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly traded